search
Back to results

Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension

Primary Purpose

Septic Shock

Status
Completed
Phase
Phase 4
Locations
Brazil
Study Type
Interventional
Intervention
norepinephrine
Sponsored by
Federal University of São Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septic Shock

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age over than 18 years old,
  • norepinephrine drug use for at least 12 hours and for less than 72 hours,
  • sedation level equal or deeper than Ramsay 4,
  • blood pressure stable for the last 30 minutes prior to inclusion,
  • central venous catheter in place and
  • signed informed consent.

Exclusion Criteria:

  • pregnancy,
  • cirrhosis,
  • systemic sclerosis, and
  • need to maintain mean arterial pressure above 65mmHg for others conditions

Sites / Locations

  • Hospital São Paulo - Universidade Federal de São Paulo

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Norepinephrine

Arm Description

Noradrenaline continuous infusion IV

Outcomes

Primary Outcome Measures

Microcirculatory flow index (MIF) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
MIF will be measured in points varying from 0 to 4

Secondary Outcome Measures

Total vascular density (TVD) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
TVD will be measured in mm/mm2
Perfused vascular density (PVD) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
PVD will be measured in mm/mm2
Proportional perfused vessels (PPV) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
PPV will be measured in percentage

Full Information

First Posted
July 28, 2015
Last Updated
April 2, 2017
Sponsor
Federal University of São Paulo
search

1. Study Identification

Unique Protocol Identification Number
NCT02519699
Brief Title
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
Official Title
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
March 2013 (undefined)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
January 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of São Paulo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The optimal levels of mean arterial pressure that must be achieved in septic shock are subject of debate. Studies tried to correlate blood pressure increase in patients with septic shock with microcirculation. However, there are few studies that specifically assessed septic shock patients with previous arterial hypertension. The main objective of this study is to evaluate the effect of increased blood pressure level in the microcirculation of these patients and compare them with patients without arterial hypertension.
Detailed Description
Hypothesis: After a rise in mean arterial pressure, microcirculation improvement will occur only in the previously hypertensive patients. Study design: Prospective clinical trial Setting: Intensive care units of the Anesthesiology Department at the Federal University of Sao Paulo and the intensive care unit of Kidney Hospital. Studied population: Forty patients will be included, being 20 without known history of systemic arterial hypertension and 20 with this diagnosis for at least 2 years and already with clinical or subclinical organ damage. Inclusion criteria: age over than 18 years old, norepinephrine drug use for at least 12 hours and for less than 72 hours, sedation level equal or deeper than Ramsay 4, blood pressure stable for the last 30 minutes prior to inclusion, central venous catheter in place and signed informed consent. Exclusion criteria: pregnancy, cirrhosis, systemic sclerosis, and need to maintain mean arterial pressure above 65mmHg for others conditions. Intervention: noradrenaline dose will be risen to obtain a mean arterial pressure of 85-90 mmHg. Assessments and outcome: Systemic hemodynamic (central venous oxygen saturation, cardiac output, heart rate, central venous pressure) and sublingual microcirculation variables (microcirculatory flow index, total vascular density, proportion of perfused vessels, perfused vascular density) will be measured before and after the rise in mean arterial pressure. Sidestream darkfield will be used to assess microcirculation. The variation between those variables before and after the intervention will be compared.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Norepinephrine
Arm Type
Experimental
Arm Description
Noradrenaline continuous infusion IV
Intervention Type
Drug
Intervention Name(s)
norepinephrine
Other Intervention Name(s)
noradrenaline
Intervention Description
Increase in mean arterial pressure using norepinephrine
Primary Outcome Measure Information:
Title
Microcirculatory flow index (MIF) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
Description
MIF will be measured in points varying from 0 to 4
Time Frame
after 20 min
Secondary Outcome Measure Information:
Title
Total vascular density (TVD) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
Description
TVD will be measured in mm/mm2
Time Frame
after 20 min
Title
Perfused vascular density (PVD) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
Description
PVD will be measured in mm/mm2
Time Frame
after 20 min
Title
Proportional perfused vessels (PPV) measured by sidestream darkfield after rising the mean arterial pressure with norepinephrine
Description
PPV will be measured in percentage
Time Frame
after 20 min

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age over than 18 years old, norepinephrine drug use for at least 12 hours and for less than 72 hours, sedation level equal or deeper than Ramsay 4, blood pressure stable for the last 30 minutes prior to inclusion, central venous catheter in place and signed informed consent. Exclusion Criteria: pregnancy, cirrhosis, systemic sclerosis, and need to maintain mean arterial pressure above 65mmHg for others conditions
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Flavia Machado, PhD
Organizational Affiliation
Federal University of São Paulo
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital São Paulo - Universidade Federal de São Paulo
City
São Paulo
ZIP/Postal Code
04024-003
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
undecided
Citations:
PubMed Identifier
25887027
Citation
Xu JY, Ma SQ, Pan C, He HL, Cai SX, Hu SL, Liu AR, Liu L, Huang YZ, Guo FM, Yang Y, Qiu HB. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study. Crit Care. 2015 Mar 30;19(1):130. doi: 10.1186/s13054-015-0866-0.
Results Reference
background
PubMed Identifier
19534818
Citation
Dubin A, Pozo MO, Casabella CA, Palizas F Jr, Murias G, Moseinco MC, Kanoore Edul VS, Palizas F, Estenssoro E, Ince C. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care. 2009;13(3):R92. doi: 10.1186/cc7922. Epub 2009 Jun 17.
Results Reference
background
PubMed Identifier
23363690
Citation
Correa TD, Vuda M, Takala J, Djafarzadeh S, Silva E, Jakob SM. Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function. Crit Care. 2013 Jan 30;17(1):R21. doi: 10.1186/cc12495.
Results Reference
background
PubMed Identifier
25888071
Citation
Leone M, Asfar P, Radermacher P, Vincent JL, Martin C. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015 Mar 10;19(1):101. doi: 10.1186/s13054-015-0794-z.
Results Reference
background
PubMed Identifier
31094744
Citation
Fiorese Coimbra KT, de Freitas FGR, Bafi AT, Pinheiro TT, Nunes NF, de Azevedo LCP, Machado FR. Effect of Increasing Blood Pressure With Noradrenaline on the Microcirculation of Patients With Septic Shock and Previous Arterial Hypertension. Crit Care Med. 2019 Aug;47(8):1033-1040. doi: 10.1097/CCM.0000000000003795.
Results Reference
derived

Learn more about this trial

Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension

We'll reach out to this number within 24 hrs